CHIR 99021
-
Catalog number1677-5
-
PricePlease ask
-
Size5 mg
-
-
Alternative_name6-((2-((4-(2,4-Dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-yl)amino)ethyl)amino)nicotinonitrile; CT99022
-
DescriptionA potent and highly selective inhibitor of glycogen synthase kinase-3β (GSK-3β) (IC₅₀ = 6.7 nM). CHIR99021 has been shown to allow for long-term expansion of murine embryonic stem cells in a chemically-defined medium in conjunction with MEK/MAPK inhibitor PD184352 and fibroblast growth factor receptor (FGFR) inhibitor SU5402.
-
CAS Number252917-06-9
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₂₂H₁₈Cl₂N₈
-
Molecular Weight465.34
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO ( 100 mM)
-
HandlingProtect from air and moisture
-
Tag LineA GSK-3β inhibitor
-
Storage Condition-20°C
-
Shipping ConditionRT
-
Shelf Life24 months
-
MDL NumberMFCD12546133
-
PubChem CID9956119
-
SMILESCC1=CN=C(N1)C2=CN=C(N=C2C3=C(C=C(C=C3)Cl)Cl)NCCNC4=NC=C(C=C4)C#N
-
InChiInChI=1S/C22H18Cl2N8/c1-13-10-29-21(31-13)17-12-30-22(32-20(17)16-4-3-15(23)8-18(16)24)27-7-6-26-19-5-2-14(9-25)11-28-19/h2-5,8,10-12H,6-7H2,1H3,(H,26,28)(H,29,31)(H,27,30,32)
-
InChi KeyAQGNHMOJWBZFQQ-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameCHIR 99021
-
Alternative nameCHIR 99021
-